Cargando…
BRCA1: A Novel Prognostic Factor in Resected Non-Small-Cell Lung Cancer
BACKGROUND: Although early-stage non-small-cell lung cancer (NSCLC) is considered a potentially curable disease following complete resection, patients have a wide spectrum of survival according to stage (IB, II, IIIA). Within each stage, gene expression profiles can identify patients with a higher r...
Autores principales: | Rosell, Rafael, Skrzypski, Marcin, Jassem, Ewa, Taron, Miquel, Bartolucci, Roberta, Sanchez, Jose Javier, Mendez, Pedro, Chaib, Imane, Perez-Roca, Laia, Szymanowska, Amelia, Rzyman, Witold, Puma, Francesco, Kobierska-Gulida, Grazyna, Farabi, Raffaele, Jassem, Jacek |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2042516/ https://www.ncbi.nlm.nih.gov/pubmed/17987116 http://dx.doi.org/10.1371/journal.pone.0001129 |
Ejemplares similares
-
Prognostic value of microRNA expression in operable non-small cell lung cancer patients
por: Skrzypski, M, et al.
Publicado: (2014) -
Rosai-Dorfman disease as a rare cause of cervical lymphadenopathy – case report and literature review
por: Miękus, Aleksandra, et al.
Publicado: (2018) -
Current and future applications of liquid biopsy in non-small-cell lung cancer—a narrative review
por: Tomasik, Bartłomiej, et al.
Publicado: (2023) -
Osimertinib – effective treatment of NSCLC with activating EGFR mutations after progression on EGFR tyrosine kinase inhibitors
por: Skrzypski, Marcin, et al.
Publicado: (2017) -
Folate/homocysteine metabolism and lung cancer risk among smokers
por: Stanisławska-Sachadyn, Anna, et al.
Publicado: (2019)